Dark

ARGX
argenx SE
stock NASDAQ ADR

At Close

Jul 22, 2025 3:59:48 PM EDT

570.83USD+0.828%(+4.69)216,576

572.80Bid 574.22Ask 1.42Spread

Pre-market

0.00USD-100.000%(-566.14)0

After-hours

Jul 22, 2025 4:00:30 PM EDT

571.23USD+0.070%(+0.40)982

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

34.94B

CEO

Tim Van Hauwermeiren

Headquarters

Breda, Noord Brabant, Netherlands

Industry

Biotechnology

Next Earnings

Oct 30, 2025 (100d)

XLV

ARGX Stats

Avg. Vol. 10 Day

392,002

Avg. Vol. 30 Day

402,928

Employees

843

Market Cap

34,942,390,046

Shares Out.

61,199,902

On/Off Exchange

58%/42%

6 Month Beta

0.50

1 Year Beta

0.47

2 Year Beta

0.61

3 Year Beta

0.58

52 Week Low

457.42

52 Week High

678.21

SMA50

564.16

SMA200

595.71

1 Week

+2.70%

1 Month

+5.58%

3 Month

-4.82%

6 Month

-10.77%

1 Year

+23.85%

2 Year

+4.11%

5 Year

+120.19%

Profile

Argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer.

ARGX Stock Summary

argenx SE (NASDAQ:ARGX) stock price today is $570.83, and today's volume is 216,576. ARGX is up 0.828% today. The 30 day average volume is 402,928. ARGX market cap is 34.94B with 61,199,902 shares outstanding.

document.getElementById("qv15yJ").onerror = function(){this.style.display='none';}; .dark-mode .q6CB8z{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .q6CB8z{ color: #333333; background-color: white; border: 2px solid #333333; }ARGXargenx SEstock NASDAQ ADR

ARGX Stock Summary

ARGX
argenx SE
stock NASDAQ ADR